Methyl wogonin has demonstrated strong anticancer effects on melanoma cells (A375) by the activation of increased DNA damage, apoptosis, decreased cellular invasion, and mTOR/PI3K/Akt signaling pathway modification. The gene discussed is AKT1; the disease is melanoma.